Загрузка...
Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme
AIM: To compare the effectiveness of dulaglutide 1.5 and 0.75 mg with active comparators and placebo with regard to a composite endpoint of glycated haemoglobin (HbA1c), weight and hypoglycaemia, using post hoc analyses. METHODS: A logistic regression analysis was performed on the intention‐to‐treat...
Сохранить в:
| Опубликовано в: : | Diabetes Obes Metab |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061097/ https://ncbi.nlm.nih.gov/pubmed/26362460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12575 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|